Apr 24, 2018 16:00 JST

Source: Showa Denko K.K.

Showa Denko provisions LEDs for research on MucoRice Oral Vaccine

TOKYO, Apr 24, 2018 - (JCN Newswire) - Showa Denko (SDK) has entered into an agreement with Astellas Pharma Inc. supporting its research on the practical applications of MucoRice-CTB, a rice-based oral vaccine, to be carried out with the Institute of Medical Science, the University of Tokyo, Chiba University and Asahi Kogyosha.

SDK will be responsible for providing Astellas with LED lighting and related equipment for plant growth, contributing to the development of MucoRice with know-how nourished through years of experience in plant factories.

Showa Denko's LED lighting systems for plant growth include LEDs that emit deep-red light with wavelengths of 660 nm, the optimal light for photosynthesis, with the highest levels of efficiency yet measured, and LEDs which emit blue light.

Using an S-method (SHIGYOTM Method) which irradiates deep-red and blue lights alternately in optimized cycles, the system creates an environment that allows a lettuce to grow to 150 grams only 30 days after seeding.

The system's equipment not only controls the lighting environment as desired, but applies to a variety of plant growth strategies as well. For more information, please visit www.sdk.co.jp/english/ or contact the SDK Public Relations Office at +81-3-5470-3235.

Source: Showa Denko K.K.
Sectors: Chemicals, Spec.Chem

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release


Showa Denko Launches Mass Production of 6-inch SiC Single Crystal Wafers
March 28 2022 11:00 JST
 
SDK Corrects Segment Information in 2021 Consolidated Financial Statements
March 11 2022 14:00 JST
 
Showa Denko Group Starts to Consider Transformation into Holding Company Structure
March 09 2022 14:00 JST
 
Showa Denko Decides Firm Name of the Newly Integrated Company
March 09 2022 14:00 JST
 
SDK Announces 2021 Consolidated Financial Results
February 14 2022 13:00 JST
 
SDK to Revise Amount of Director Compensation (in Money) Following Revision of Director Compensation Scheme and to Partially Revise Performance-Linked Stock Compensation Scheme
February 14 2022 13:00 JST
 
Showa Denko Accelerates Search for Optimal Formulation of Semiconductor Materials with Quantum Computing Technology
February 10 2022 12:00 JST
 
Showa Denko Revises Forecast of Consolidated Performance
February 09 2022 15:00 JST
 
New Year Message from Hidehito Takahashi, Showa Denko President and CEO
January 04 2022 13:00 JST
 
Showa Denko Develops HD Media for MAS-MAMR Technology
December 10 2021 12:30 JST
 
More Press release >>

Latest Press Release


More Latest Release >>